Skip to main content
Atrium Therapeutics, Inc. logo

Atrium Therapeutics, Inc. — Investor Relations & Filings

Ticker · RNA ISIN · US04965N1046 Manufacturing
Filings indexed 14 across all filing types
Latest filing 2026-05-15 Major Shareholding Noti…
Country US United States of America
Listing RNA

About Atrium Therapeutics, Inc.

https://atriumtherapeutics.com/

Atrium Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering precision RNA medicines for cardiac diseases. The company develops and delivers targeted RNA therapeutics directly to the heart, aiming to transform the standard of care for patients with rare, life-threatening genetic cardiomyopathies. Its initial focus includes PLN cardiomyopathy and PRKAG2 Syndrome, conditions characterized by high unmet medical need and a lack of approved treatment options. This approach seeks to provide novel therapeutic solutions by delivering RNA medicines to hard-to-reach cardiac muscle tissue.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2026
Major Shareholding Notification
2026-05-15 English
10-Q
Interim / Quarterly Report
2026-05-14 English
8-K
Regulatory Filings
2026-05-14 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-27 English
S-8
Registration Form
2026-04-17 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-08 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.